Zhang, Yun http://orcid.org/0000-0003-1614-1943
Donaher, Joana Liu
Das, Sunny
Li, Xin
Reinhardt, Ferenc
Krall, Jordan A.
Lambert, Arthur W.
Thiru, Prathapan
Keys, Heather R. http://orcid.org/0000-0003-1371-2288
Khan, Mehreen
Hofree, Matan
Wilson, Molly M.
Yedier-Bayram, Ozlem
Lack, Nathan A.
Onder, Tamer T. http://orcid.org/0000-0002-2372-9158
Bagci-Onder, Tugba http://orcid.org/0000-0003-3646-2613
Tyler, Michael http://orcid.org/0000-0003-2128-5247
Tirosh, Itay http://orcid.org/0000-0001-5477-2987
Regev, Aviv http://orcid.org/0000-0003-3293-3158
Lees, Jacqueline A. http://orcid.org/0000-0001-9451-2194
Weinberg, Robert A. http://orcid.org/0000-0002-0895-3557
Article History
Received: 26 April 2021
Revised: 7 February 2022
Accepted: 23 February 2022
First Online: 11 April 2022
Competing interests
: A.R. is a co-founder and equity holder of Celsius Therapeutics, an equity holder of Immunitas and was a SAB member of Neogene Therapeutics, Thermo Fisher Scientific, Asimov and Syros Pharmaceuticals until 31 July 2020. Since 1 August 2020, A.R. has been an employee of Genentech, a member of the Roche group. R.A.W. has a consulting agreement with Verastem Inc., together with holding shares of this company. The other authors declare no competing interests.